Arch Therapeutics, Inc.
ARTH
$0.20
$0.042627.07%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -284.91% | 45.22% | -9.14% | -34.78% | -102.01% |
| Total Depreciation and Amortization | -33.33% | -14.29% | 0.00% | 133.33% | -25.00% |
| Total Amortization of Deferred Charges | -1.66% | -58.45% | 22.26% | 31.03% | 33.64% |
| Total Other Non-Cash Items | -- | -100.00% | -27.45% | -13.56% | 103.79% |
| Change in Net Operating Assets | 2.80% | -55.41% | 113.85% | 45.26% | -72.74% |
| Cash from Operations | -30.19% | 18.83% | 29.68% | -36.68% | -49.61% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 52.00% | -34.21% | 228.38% | -174.75% | 36.55% |
| Total Debt Repaid | 66.63% | 0.00% | -1.86% | -189.27% | 66.70% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 75.76% | -38.43% | -38.15% | 43.24% | 54.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 102.01% | -961.54% | -112.41% | 138.95% | 201.59% |